PEAK6 Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.36M Sell
41,700
-214,300
-84% -$6.46M 0.01% 1699
2018
Q1
$6.99M Buy
256,000
+173,200
+209% +$4.71M 0.03% 626
2017
Q4
$2.05M Buy
82,800
+19,600
+31% +$541K 0.01% 1382
2017
Q3
$1.84M Sell
63,200
-110,800
-64% -$3.06M 0.01% 1457
2017
Q2
$4.82M Sell
174,000
-111,600
-39% -$2.96M 0.03% 731
2017
Q1
$7.1M Buy
285,600
+90,300
+46% +$2.2M 0.06% 405
2016
Q4
$4.22M Sell
195,300
-153,300
-44% -$3.34M 0.03% 808
2016
Q3
$8.3M Buy
348,600
+114,500
+49% +$2.73M 0.06% 431
2016
Q2
$5.47M Sell
234,100
-60,900
-21% -$1.32M 0.04% 624
2016
Q1
$5.55M Buy
295,000
+64,200
+28% +$1.13M 0.04% 553
2015
Q4
$4.26M Buy
230,800
+19,100
+9% +$342K 0.03% 831
2015
Q3
$3.47M Sell
211,700
-185,200
-47% -$3.17M 0.02% 1141
2015
Q2
$7.03M Sell
396,900
-321,300
-45% -$5.74M 0.04% 628
2015
Q1
$12.7M Buy
718,200
+699,200
+3,680% +$11.1M 0.1% 237
2014
Q4
$252K Sell
19,000
-68,100
-78% -$871K ﹤0.01% 3187
2014
Q3
$1.03M Buy
87,100
+77,100
+771% +$971K 0.01% 1802
2014
Q2
$128K Buy
+10,000
New +$130K ﹤0.01% 3553
2014
Q1
Sell
-27,400
Closed -$329K 4880
2013
Q4
$329K Sell
27,400
-195,200
-88% -$2.31M ﹤0.01% 3062
2013
Q3
$1.31M Buy
+222,600
New +$2.41M 0.01% 1905

Other funds holding BSX

PEAK6 Group's BSX Position: Q2 2018 in Review

PEAK6 Group opened a new position in Boston Scientific (BSX) in Q2 2018: 5,731 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3385 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in BSX as recently as Q3 2015.

PEAK6 Group first reported a position in BSX in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.55M in Q4 2013. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

  • PEAK6 Group held 5,731 shares of Boston Scientific worth $187K as of Q2 2018.
  • Boston Scientific was a new PEAK6 Group position in Q2 2018.
  • Boston Scientific made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3385 holding.
  • PEAK6 Group first reported a position in Boston Scientific in Q2 2013 and has held it in 7 quarters since.
  • PEAK6 Group's Boston Scientific position peaked at $3.55M in Q4 2013.
  • 671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.